Search Browse Earnings

Cytek Biosciences, Inc. — SlamSEC

Cytek Biosciences, Inc.

Nasdaq:CTKB

Laboratory Analytical Instruments·FREMONT, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$193.0M

+17.7% YoY

FY 2025

Adj. EBITDA

-$21.8M

-11.3% margin

FY 2025

Net Income

-$12.1M

-6.3% margin

FY 2025

EPS (Diluted)

$0.00

FY 2023

Stock Price

$4.01

+0.2%

2026-03-13

52W Range

$2.37 – $6.18

P/E Ratio

—

Market Cap

$515.5M

Cash

$98.7M

FY 2025

Total Debt

—

Net Cash

$98.7M

FY 2025

Enterprise Value

$416.8M

Debt / EBITDA

4.5x

FY 2025

EV / EBITDA

-19.1x

Employees

—